A detailed history of Notis Mc Conarty Edward transactions in Merck & Co., Inc. stock. As of the latest transaction made, Notis Mc Conarty Edward holds 11,600 shares of MRK stock, worth $1.17 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
11,600
Previous 13,000 10.77%
Holding current value
$1.17 Million
Previous $1.72 Million 16.27%
% of portfolio
0.57%
Previous 0.69%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $173,320 - $186,144
-1,400 Reduced 10.77%
11,600 $1.44 Million
Q1 2024

Apr 29, 2024

SELL
$113.24 - $131.95 $379,354 - $442,032
-3,350 Reduced 20.49%
13,000 $1.72 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $155,279 - $168,981
-1,550 Reduced 8.66%
16,350 $1.78 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $10,861 - $11,838
-100 Reduced 0.56%
17,900 $2.07 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $7,205 - $8,040
-70 Reduced 0.39%
18,000 $1.92 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $8,744 - $11,211
-100 Reduced 0.55%
18,070 $2 Million
Q3 2022

Nov 08, 2022

SELL
$84.53 - $94.96 $1,267 - $1,424
-15 Reduced 0.08%
18,170 $1.57 Million
Q1 2022

May 17, 2022

SELL
$73.51 - $82.4 $14,702 - $16,480
-200 Reduced 1.09%
18,185 $1.49 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $14,456 - $18,108
-200 Reduced 1.08%
18,385 $1.41 Million
Q3 2021

Nov 10, 2021

SELL
$71.68 - $78.83 $7,168 - $7,883
-100 Reduced 0.54%
18,585 $1.4 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $1,032 - $1,216
-15 Reduced 0.08%
18,685 $1.44 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $21,531 - $23,895
-300 Reduced 1.58%
18,700 $1.53 Million
Q3 2020

Oct 28, 2020

BUY
$73.18 - $82.95 $3,659 - $4,147
50 Added 0.26%
19,000 $1.58 Million
Q2 2020

Jul 28, 2020

SELL
$70.42 - $80.13 $17,605 - $20,032
-250 Reduced 1.3%
18,950 $1.47 Million
Q1 2020

May 07, 2020

SELL
$63.36 - $87.82 $19,008 - $26,345
-300 Reduced 1.54%
19,200 $1.48 Million
Q4 2019

Jan 15, 2020

SELL
$77.58 - $87.54 $23,274 - $26,262
-300 Reduced 1.52%
19,500 $1.77 Million
Q3 2019

Nov 04, 2019

SELL
$76.08 - $82.93 $26,628 - $29,025
-350 Reduced 1.74%
19,800 $1.67 Million
Q2 2019

Jul 24, 2019

SELL
$69.84 - $81.59 $1,746 - $2,039
-25 Reduced 0.12%
20,150 $1.69 Million
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $73,059 - $83,328
-1,050 Reduced 4.95%
20,175 $1.68 Million
Q4 2018

Jan 24, 2019

SELL
$65.24 - $75.71 $49,256 - $57,161
-755 Reduced 3.43%
21,225 $1.62 Million
Q2 2018

Jul 30, 2018

SELL
$50.83 - $59.72 $12,707 - $14,930
-250 Reduced 1.12%
21,980 $1.34 Million
Q1 2018

Apr 24, 2018

SELL
$50.96 - $59.23 $30,576 - $35,538
-600 Reduced 2.63%
22,230 $1.21 Million
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $201,318 - $240,396
3,900 Added 20.6%
22,830 $1.29 Million
Q3 2017

Oct 26, 2017

BUY
$58.67 - $63.13 $1.11 Million - $1.2 Million
18,930
18,930 $1.21 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Notis Mc Conarty Edward Portfolio

Follow Notis Mc Conarty Edward and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.